ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,834Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 122

$405K Total Retail Price of All Prescriptions

Rank: 30 out of 122

278 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 278 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

9% of this provider’s 278 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,622 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
LEVOTHYROXINE SODIUM 407 338 1 4
OMEPRAZOLE 354 284 2 3
LISINOPRIL 315 297 3 2
PRAVASTATIN SODIUM 312 288 4 27
LOSARTAN POTASSIUM 296 254 5 17
SIMVASTATIN 288 236 6 1
AMLODIPINE BESYLATE 221 180 7 7
FUROSEMIDE 193 188 8 5
ATENOLOL 175 169 9 10
SERTRALINE HCL 156 143 10 18
GABAPENTIN 155 144 11 12
WARFARIN SODIUM 141 134 12 9
METOPROLOL SUCCINATE 140 112 13 11
HYDROCHLOROTHIAZIDE 128 114 14 6
CITALOPRAM HBR 127 103 15 15
POTASSIUM CHLORIDE 105 103 16 22
ZOLPIDEM TARTRATE 95 62 17 19
LOSARTAN-HYDROCHLOROTHIAZIDE 92 82 18 55
DONEPEZIL HCL 90 90 19 25
CLOPIDOGREL 82 82 20 45
METOPROLOL TARTRATE 77 73 21 8
DILTIAZEM 24HR CD 75 75 22 66
LANTUS 74 58 23 36
HYDROCODONE-ACETAMINOPHEN 72 48 S3 24 16
MIRTAZAPINE 70 67 25 61
METFORMIN HCL ER 70 33 25 84
PANTOPRAZOLE SODIUM 63 53 27 23
TRIAMCINOLONE ACETONIDE 61 58 28 83
FLUOXETINE HCL 60 31 29 38
GLYBURIDE 60 51 R 29 73
PLAVIX 57 57 31 81
SPIRIVA 56 44 32 29
PHENYTOIN SODIUM EXTENDED 54 54 33 162
PROAIR HFA 54 33 33 31
AZITHROMYCIN 52 44 35 53
SINGULAIR 52 40 35 112
QUETIAPINE FUMARATE 51 51 37 46
FAMOTIDINE 50 39 38 58
ALENDRONATE SODIUM 50 36 38 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.